0001209191-23-035974.txt : 20230609
0001209191-23-035974.hdr.sgml : 20230609
20230609173311
ACCESSION NUMBER: 0001209191-23-035974
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230608
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fardis Maria
CENTRAL INDEX KEY: 0001559231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 231006489
MAIL ADDRESS:
STREET 1: C/O PARMACYCLICS, INC.
STREET 2: 995 EAST ARQUES AVENUE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-08
0
0001674416
CRISPR Therapeutics AG
CRSP
0001559231
Fardis Maria
C/O CRISPR THERAPEUTICS
105 WEST FIRST STREET
BOSTON
MA
02127
1
0
0
0
0
Stock Option (Right to Buy)
62.59
2023-06-08
4
A
0
13000
0.00
A
2033-06-08
Common Shares
13000
13000
D
This option was granted on June 8, 2023 with respect to 13,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2023; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2024 Annual General Meeting of Shareholders.
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
2023-06-09